CA
KRRO icon

Cliff Asness’s Korro Bio KRRO Stock Holding History

Cliff Asness’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.94M Buy
298,974
+31,219
+12% +$388K ﹤0.01% 2155
2026
Q1 		$3.03M Buy
267,755
+227,108
+559% +$2.5M ﹤0.01% 2077
2025
Q4 		$326K Sell
40,647
-7,760
-16% -$181K ﹤0.01% 3134
2025
Q3 		$2.32M Buy
+48,407
New +$1.07M ﹤0.01% 1893
2022
Q3 		– Sell
-2,016
Closed -$151K – 2260
2022
Q2 		$151K Buy
2,016
+1,432
+245% +$96.8K ﹤0.01% 2033
2022
Q1 		$62K Buy
+584
New +$112K ﹤0.01% 2176

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Cliff Asness's KRRO Position: Q2 2026 in Review

Cliff Asness increased its Korro Bio (KRRO) stake by 12% in Q2 2026, buying an estimated $388K and bringing the position to 298,974 shares worth $3.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2155.

Cliff Asness first reported a position in KRRO in Q1 2022 and has held it in 6 quarters since. 106 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Cliff Asness held 298,974 shares of Korro Bio worth $3.94M as of Q2 2026.
  • Cliff Asness bought 31,219 Korro Bio shares in Q2 2026, an estimated $388K.
  • Korro Bio made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2155 holding.
  • Cliff Asness first reported a position in Korro Bio in Q1 2022 and has held it in 6 quarters since.
  • 106 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.